<DOC>
	<DOCNO>NCT01012310</DOCNO>
	<brief_summary>The purpose study determine safety toleration single multiple dos PF-04531083 . ( To investigate plasma urinary pharmacokinetics PF-04531083 metabolite , follow single multiple dose administration healthy male and/or female subject ; determine whether PF-04531083 raise level enzymes involved metabolism drug follow multiple dose ) .</brief_summary>
	<brief_title>Group Study To Investigate The Safety , Toleration And Pharmacokinetics Of Multiple Oral Doses Of PF-04531083 In Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male and/or female subject btween age 1855 year Body Mass Index ( BMI ) 15.5 30.5 total body weight great 50kg ( 110 lb ) . Evidence history clinically signifcant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease . A positive urine drug screen . History regular alcohol consumption exceed 21 drinks/week within 6 month screen Use tobacco nicotine containing product excess equivalent 5 cigarette per day . Pregnant nursing female ; female childbearing potentioal unwilling unable use acceptable method contraception .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>pharmacokinetics safety tolerability multiple dose</keyword>
</DOC>